Return to Index

• Biotech ETFs Break Out

  January 19th by John Spence

  The rally in biotechnology exchange traded funds is going vertical in early 2012 with the sector's...

  READ MORE

• Biotech ETFs: Orexigen Hit By Regulatory Hammer

  June 3rd by Tom Lydon

  Biotech sector and related exchange traded funds (ETFs) trade lower as one drug maker garners...

  READ MORE

• Teva, Cephalon Boost Biotech ETFs

  May 2nd by John Spence

  Biotechnology exchange traded funds (ETFs) rallied to open the week after Teva Pharmaceutical...

  READ MORE

• ETFs And A Global Approach Help Investors Access Biotech

  March 11th by Tom Lydon

  Investing in biotech stocks and companies is so much like gambling, the risk is sometimes not worth...

  READ MORE

• 5 Biotechnology ETFs to Play Innovation

  February 22nd by Tom Lydon

  While the broader market has picked up its pace, the biotechnology sector has not seen a similar...

  READ MORE

• 5 ETFs That Could Move on Obama’s Budget

  February 14th by Tom Lydon

  President Obama is out with a new budget. If it goes through, the impact could be ugly for some...

  READ MORE

• Sector ETFs to Play the State of the Union Address

  January 26th by Tom Lydon

  In his State of the Union address Tuesday, President Barack Obama touched upon the major problems...

  READ MORE

• « Older Entries